HIDRADENITIS SUPPURATIVA

This Phase 3 study tested whether bimekizumab, an injectable medication, could reduce symptoms in adults with moderate-to-severe hidradenitis suppurativa (HS), a painful chronic skin condition. Over 500 participants received either the drug or a placebo for 16 weeks to see if it …

This study tested whether an experimental drug called ATI-450 could reduce painful skin lumps and improve quality of life for people with moderate-to-severe hidradenitis suppurativa. 95 participants received either the drug or a placebo for 12 weeks. Researchers measured changes …

This study tested whether a medicine called spesolimab helps adults with moderate to severe hidradenitis suppurativa, a chronic skin condition that causes painful lumps and boils. Participants were randomly assigned to receive either spesolimab or a placebo (dummy treatment) as i…

This study tested whether a drug called spesolimab helps adults with moderate to severe hidradenitis suppurativa (HS), a chronic skin condition that causes painful lumps and tunnels under the skin. Over 200 participants received either spesolimab injections or a placebo (dummy tr…

This study tested an experimental drug called SAR442970 for adults with moderate-to-severe hidradenitis suppurativa (HS), a chronic skin condition causing painful lumps and tunnels under the skin. The main goal was to see if the drug was better than a placebo (a dummy shot withou…

This study followed adults with hidradenitis suppurativa (HS) for about two years to see if a medicine called spesolimab is safe and effective for long-term use. Participants received injections every two weeks, and doctors tracked their skin symptoms and any side effects. The go…

This study tested whether a new drug called imsidolimab could reduce painful lumps and sores in people with hidradenitis suppurativa (HS), a chronic inflammatory skin disease. 149 adult participants with moderate to severe HS were randomly assigned to receive either the drug or a…

This study tested whether the drug tofacitinib is safe and effective for treating several common autoimmune skin conditions in adolescents and adults with Down syndrome. Researchers wanted to see if reducing overactive immune signaling could improve skin health, quality of life, …

This completed Phase 3 trial tested whether the drug bimekizumab could reduce painful skin lesions and improve quality of life for people with moderate to severe hidradenitis suppurativa (HS), a chronic inflammatory skin disease. The study involved 505 adults whose HS did not res…

This study looked at whether switching patients to a higher concentration version of the drug adalimumab (brand name SIMLANDI™) causes less injection site pain than the standard version. It involved 324 Canadian adults with conditions like Crohn's disease, rheumatoid arthritis, o…

This study tested whether mindfulness training could improve quality of life for people with hidradenitis suppurativa (HS), a painful chronic skin condition. Researchers enrolled 37 HS patients from the University of Miami's dermatology system to participate in mindfulness sessio…

This small study tested whether a special bioelectric dressing could help skin heal better after surgery for hidradenitis suppurativa (HS), a painful skin condition. Researchers enrolled 12 adults with HS to see if the dressing could speed up healing, reduce pain, and improve sca…

This study aimed to understand the specific inflammatory process that drives hidradenitis suppurativa (HS), a chronic skin condition. Researchers examined small skin samples from 20 participants (10 with HS and 10 without) after surgery. The goal was to identify key immune signal…

This study aimed to better understand how Hidradenitis Suppurativa (HS), a painful and chronic skin condition, affects people's daily lives, mental health, and social well-being. Researchers surveyed 67 adults diagnosed with HS to measure its impact and test a simple photo-based …